Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved..
Familial hypertrophic cardiomyopathy (HCM) stands as a predominant heart condition, characterised by left ventricle hypertrophy in the absence of any associated loading conditions, with affected individuals having an increased risk of developing heart failure and sudden cardiac death (SCD). Two induced pluripotent stem cell (iPSC) lines were derived from peripheral blood mononuclear cells obtained from two unrelated individuals with previously reported nonsense mutations in the MYBPC3 gene. The first individual is a 48-year-old male (F26) with the MYBPC3 c.1731G > A HCM mutation, whereas the second individual is a 43-year-old female (F82) carrying the MYBPC3 c.2670G > A HCM mutation. The generated iPSCs exhibit appropriate expression of pluripotency markers, trilineage differentiation capacity and a normal karyotype. This resource contributes to gaining deeper insights into the pathophysiological mechanisms that underlie HCM.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
|---|---|
| Enthalten in: |
Stem cell research - 76(2024) vom: 30. März, Seite 103362 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ribeiro, Marta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.scr.2024.103362 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369072944 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369072944 | ||
| 003 | DE-627 | ||
| 005 | 20240325235004.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.scr.2024.103362 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1346.xml |
| 035 | |a (DE-627)NLM369072944 | ||
| 035 | |a (NLM)38417376 | ||
| 035 | |a (PII)S1873-5061(24)00060-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ribeiro, Marta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Generation of induced pluripotent stem cell lines from two unrelated individuals with familial hypertrophic cardiomyopathy carrying MYBPC3 nonsense mutations |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.03.2024 | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Familial hypertrophic cardiomyopathy (HCM) stands as a predominant heart condition, characterised by left ventricle hypertrophy in the absence of any associated loading conditions, with affected individuals having an increased risk of developing heart failure and sudden cardiac death (SCD). Two induced pluripotent stem cell (iPSC) lines were derived from peripheral blood mononuclear cells obtained from two unrelated individuals with previously reported nonsense mutations in the MYBPC3 gene. The first individual is a 48-year-old male (F26) with the MYBPC3 c.1731G > A HCM mutation, whereas the second individual is a 43-year-old female (F82) carrying the MYBPC3 c.2670G > A HCM mutation. The generated iPSCs exhibit appropriate expression of pluripotency markers, trilineage differentiation capacity and a normal karyotype. This resource contributes to gaining deeper insights into the pathophysiological mechanisms that underlie HCM | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Codon, Nonsense |2 NLM | |
| 650 | 7 | |a Cytoskeletal Proteins |2 NLM | |
| 700 | 1 | |a Jager, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Furtado, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Carvalho, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Cabral, Joaquim M S |e verfasserin |4 aut | |
| 700 | 1 | |a Brito, Dulce |e verfasserin |4 aut | |
| 700 | 1 | |a Carmo-Fonseca, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Martins, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a da Rocha, Simão Teixeira |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Stem cell research |d 2007 |g 76(2024) vom: 30. März, Seite 103362 |w (DE-627)NLM18622009X |x 1876-7753 |7 nnns |
| 773 | 1 | 8 | |g volume:76 |g year:2024 |g day:30 |g month:03 |g pages:103362 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.scr.2024.103362 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 76 |j 2024 |b 30 |c 03 |h 103362 | ||